23769410
Results 1 to 1 of 1
Selection :
Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)FURY, Matthew G; BAXI, Shrujal; SHEN, Ronglai et al.Anticancer research. 2011, Vol 31, Num 1, pp 249-253, issn 0250-7005, 5 p.Article
